Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
480
datasets available to search
ShareScore release 0.7.1
Dataset results
480 results for “Hormone Receptors”
Fasting-Mimicking Diet as an Adjunct to Neoadjuvant Chemotherapy for Hormone-Receptor-Positive Breast Cancer
ClinicalTrials.gov study NCT07077018. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or M
ClinicalTrials.gov study NCT04274933. IPD Sharing: NO. Countries: 4. Publications: 0.
Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy
ClinicalTrials.gov study NCT04278469. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer
ClinicalTrials.gov study NCT05047848. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil
ClinicalTrials.gov study NCT05034393. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients
ClinicalTrials.gov study NCT05730647. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus Pertuzumab
ClinicalTrials.gov study NCT05760612. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Receptor Positive HER2-negative Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov study NCT03430466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT04553770. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Be
ClinicalTrials.gov study NCT05625087. IPD Sharing: NO. Countries: 1. Publications: 0.
Uterine Cavity Assessment and Endometrial Hormonal Receptors in Women With Peri and Post Menopausal Bleeding
ClinicalTrials.gov study NCT02385747. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
ClinicalTrials.gov study NCT02132390. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast Cancer
ClinicalTrials.gov study NCT00647790. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients
ClinicalTrials.gov study NCT03393845. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of the Gut Microbiome in Hormone Receptor-positive HER2-negative Breast Cancer Treated With CDK4/6 Inhibitors
ClinicalTrials.gov study NCT06171360. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Iparomlimab and Tuvonralimab (QL1706) in Patients With Hormone Receptor Positive, HER2-negative Breast Cancer
ClinicalTrials.gov study NCT07396324. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy
ClinicalTrials.gov study NCT04476485. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer
ClinicalTrials.gov study NCT01171417. IPD Sharing: Not stated. Countries: 1. Publications: 0.
G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT02983071. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Ca
ClinicalTrials.gov study NCT05098210. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.